How big is the Pharmaceutical Intermediates Market?

The Pharmaceutical Intermediates Market size is expected to reach USD 42.31 billion in 2024 and grow at a CAGR of 7.42% to reach USD 60.52 billion by 2029. Read More

What is the current Pharmaceutical Intermediates Market size?

In 2024, the Pharmaceutical Intermediates Market size is expected to reach USD 42.31 billion. Read More

Who are the key players in Pharmaceutical Intermediates Market?

Chiracon GmbH , BASF SE, Sanofi SAIS, Aceto and Codexis, Inc. are the major companies operating in the Pharmaceutical Intermediates Market. Read More

Which is the fastest growing region in Pharmaceutical Intermediates Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Pharmaceutical Intermediates Market?

In 2024, the North America accounts for the largest market share in Pharmaceutical Intermediates Market. Read More

What years does this Pharmaceutical Intermediates Market cover, and what was the market size in 2023?

In 2023, the Pharmaceutical Intermediates Market size was estimated at USD 39.39 billion. The report covers the Pharmaceutical Intermediates Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Pharmaceutical Intermediates Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Pharmaceutical Intermediates Market Share

Statistics for the 2023 & 2024 Pharmaceutical Intermediates market share, created by Mordor Intelligence™ Industry Reports. Pharmaceutical Intermediates share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Pharmaceutical Intermediates Industry

The global pharmaceutical intermediates market is competitive and consists of a few major players. Companies like Aceto Corporation, BASF SE, Chiracon GmbH, Yin-sheng Bio-tech Co., Ltd., Dishman Group, Green Vision Life Sciences, Codexis, Inc., Sanofi SAIS, Vertellus Holdings LLC., among others, hold the substantial market share in the market.